Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Here's is How to Trade

Core Viewpoint - Pharming Group N.V. (PHAR) shares have increased by 24% in the past four weeks, closing at $17.06, with a mean price target of $31 indicating a potential upside of 81.7% [1] Price Targets and Analyst Estimates - The mean estimate includes three short-term price targets with a standard deviation of $14.93, where the lowest estimate of $14.00 suggests a 17.9% decline, while the highest target of $42.00 indicates a potential surge of 146.2% [2] - A low standard deviation among price targets suggests a strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about PHAR's earnings prospects, with a positive trend in earnings estimate revisions, which historically correlates with stock price movements [11] - Over the last 30 days, two earnings estimates have been revised upward, leading to a 520% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - PHAR holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the implied direction of price movement appears to be a useful guide for potential investment [14]